Medi Futures commercializes products built on an ultrasonic platform, including ultrasonic endoscopic disk surgical instruments and enzyme-free ultrasound stem cell separators. The company has recently developed and exported medical sutures with high-precision anchoring points (barbed sutures). It operates from Seoul, South Korea, and is a member of the K-ICT Born2Global Centre. Medi Futures also participated in a training program at Medtronic’s Asia‑Pacific Headquarters. The company raised US$5M in funding through common stocks to support its operations and regulatory progress. The investment is expected to accelerate efforts to obtain FDA and CFDA approvals.

Total raised

$5M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2018